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Heart Failure With Preserved Ejection Fraction
in Outpatients With Unexplained Dyspnea
A Pressure-Volume Loop Analysis
Martin Penicka, MD, PHD,* Jozef Bartunek, MD, PHD,* Helena Trakalova, RN,†
Hana Hrabakova, MD,† Michaela Maruskova, MD,† Jiri Karasek, MD,† Viktor Kocka, MD†
Aalst, Belgium; and Prague, Czech Republic
Objectives The aim of the present study was to diagnose heart failure with preserved ejection fraction (HFPEF) in outpa-
tients with unexplained chronic dyspnea and to elucidate its underlying mechanisms in this population using
invasive pressure-volume loop analysis.
Background The diagnosis of HFPEF in stable outpatients with unexplained dyspnea is difficult.
Methods Thirty patients (age 67  8.6 years, 27% males) with preserved left ventricular (LV) ejection fraction (50%)
and unexplained chronic New York Heart Association functional class II to III dyspnea underwent heart catheter-
ization. Patients with significant coronary artery stenosis (50%) were excluded. Pressure-volume loops were
assessed using a conductance catheter at rest, hand-grip exercise, leg lifting, and nitroprusside and dobutamine
infusion.
Results Twenty (66%) patients showed LV end-diastolic pressure 16 mm Hg (HFPEF), whereas the remaining 10 pa-
tients served as controls. Patients with HFPEF had significantly higher end-diastolic stiffness (0.205  0.074 vs.
0.102  0.017, p  0.001) at rest, and their end-diastolic pressure-volume relationship showed a consistent
upward and leftward shift during all hemodynamic interventions compared with controls. Regarding the underly-
ing mechanism of HFPEF, 14 (70%) patients had markedly increased end-diastolic stiffness, which was consid-
ered a sufficient single pathology to induce increased LV end-diastolic pressure. Four (20%) patients showed a
concomitant presence of moderately increased stiffness and severe LV dyssynchrony, and the remaining 2 (10%)
patients, with normal stiffness, showed significant exercise-induced mitral regurgitation at hand-grip exercise. If
the invasive pressure measurements were absent, only 5 (25%) of the outpatients with HFPEF fulfilled the Euro-
pean Society of Cardiology definition of HFPEF.
Conclusions A significant proportion of stable outpatients with unexplained chronic dyspnea may have HFPEF. In the patients
whom we studied, increased LV stiffness, dyssynchrony, and dynamic mitral regurgitation were the major mech-
anisms underlying development of HFPEF. (J Am Coll Cardiol 2010;55:1701–10) © 2010 by the American
College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.11.076o
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dhronic dyspnea is associated with a variety of diseases and
s also a major symptom of heart failure. The differential
iagnosis of dyspnea is a daily routine in every cardiology
ractice. Many causes of moderate dyspnea, without appar-
nt pathology, on routine examinations remain unexplained
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009; accepted November 19, 2009.r are attributed simply to deconditioning or mild over-
eight. Other patients, without a defined diagnosis, are
dministered thiazide-type diuretics. Recent studies showed
hat half of the patients hospitalized for heart failure have
reserved left ventricular (LV) ejection fractions (1,2). This
uggests that the diagnosis of heart failure with preserved
jection fraction (HFPEF) in stable outpatients with
hronic dyspnea is difficult.
See page 1711
The aim of the present study was to diagnose HFPEF in
utpatients referred to cardiology for unexplained chronic
yspnea and to elucidate its underlying mechanisms using
nvasive pressure-volume (P-V) loop analysis.
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Patients. The study population
consisted of 30 patients (age 67
 8.6 years, 27% males) with
preserved LV ejection fraction
(50%) who were referred, elec-
tively, for cardiology assessment
for unexplained chronic New
York Heart Association func-
tional class II to III dyspnea.
Symptoms were confirmed using
an upright bicycle ergometry be-
ginning at 25 W and increasing
25 W every 2 min until exhaus-
tion. To be eligible for the study,
patients had to have a sinus
rhythm, normal lung function
tests, no overt lung pathology
Baseline Clinical, Echocardiographic, andHemodynamic Characteristics for the HFPEF anTable 1 Baseline Clinical, Echo ardiographiHemodynamic Characteristics for th
HF
(n 
Age, yrs 67
Males 5
NYHA functional class II/III 10 (50
Duration of dyspnea, yrs 1.3
Concomitant diseases
Arterial hypertension 14
Diabetes mellitus 6
Previous PCI/MI 3 (15
Medication
Diuretics 9
ACE inhibitors/ARBs 10
Beta-blockers 10
Body mass index, kg/m2 31.4
Body surface area, m2 2.03
Creatinine, mol/ml 100
Heart rate, beats/min 71
Systolic blood pressure, mm Hg 128
Physical findings
Pulmonary rales 6
Increased jugular venous pressure 3
Hepatomegaly
Peripheral edema 5
Third heart sound 4
Cardiac murmur 6
Bicycle ergometry
Exercise duration, min 4.3
Peak work, W 54
Peak heart rate, beats/min 109
Increase in heart rate 0 ¡ 25 W, % 26
Increase in heart rate 0 ¡ 50 W, % 41
BNP, pg/ml 68
Chest X-ray
Hilus hyperemia 6
Heart enlargement 3
Abbreviations
and Acronyms
BNP  brain natriuretic
peptide
CON  control
EA  effective arterial
elastance
EDP  end-diastolic
pressure
EED  end-diastolic
stiffness
HFPEF  heart failure with
preserved ejection fraction
LV  left ventricular
P-V  pressure-volume
  relaxation time
constantchest X-ray), normal blood counts, and normal D-dimers.
atients with a history of recent (6 months) acute coronary
yndrome, the presence of significant (50%) stenosis of any
oronary artery, coronary artery bypass grafting, more than
oderate mitral regurgitation or more than mild disease of the
ther valves, hypertrophic cardiomyopathy, atrial fibrillation,
ulmonary disease, or anemia were excluded. Patients with a
istory of coronary artery disease, post-percutaneous coronary
ntervention (6 months), or post-myocardial infarction (6
onths) were not excluded provided they showed preserved
V ejection fractions and had no significant coronary artery
tenosis. The study protocol was approved by the medical
thics committees of all involved institutions, and informed
onsent was obtained from all patients.
tudy protocol. All patients underwent right and left heart
atheterization to assess the P-V relationship. Steady-state
-V loops were recorded at rest and during hemodynamic
nterventions in the following sequence: at rest, at the end of
ustained hand-grip exercise (increased afterload), during
Groupsd
PEF and CON Groups
CON
(n  10)
p Value
HFPEF vs. CON
66 9.0 0.79
3 (33) 1
0) 5 (50)/5 (50) 1
1.2 1.02 0.93*
7 (70) 1
2 (20) 0.68
) 1 (10)/1 (10) 1.00/1.00
3 (30) 0.69
4 (40) 0.71
4 (40) 0.71
28.5 4.5 0.23
1.94 0.25 0.49
87 25 0.29
75 15 0.43
138 20 0.52
3 (30) 1
1 (10) 1
1 NA
2 (20) 1
1 (10) 0.64
2 (20) 0.68
7.3 3.2 0.001
91 24 0.001
126 26 0.046
24 15 0.81
38 22 0.63
) 21 (6–115) 0.09
2 (20) 0.68
2 (20) 1d CONc, an
e HF
PEF
20)
 8.5
(25)
)/10 (5
 0.84
(70)
(30)
)/2 (10
(45)
(50)
(50)
 6.4
 0.34
 31
11
 42
(30)
(15)
0
(25)
(20)
(30)
 3.5
 19
 20
 12
 28
(5–584
(30)
(15)Continued on next page
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April 20, 2010:1701–10 HFPEF in Outpatients With Unexplained Dyspneaeg lift (increased preload), intravenous nitroprusside infu-
ion (decreased afterload), and intravenous dobutamine
nfusion (increased contractility). Nitroprusside was titrated
t increasing doses starting at 0.5 g/kg/min to achieve a
ecrease in systolic blood pressure of 20 mm Hg. P-V
oops were recorded during steady states. Dobutamine was
dministered in 3 increasing doses (5 g/kg/min, 10 g/
g/min and 20 g/kg/min; dose intervals  3 min) pro-
ided there was no significant increase in heart rate or
nduction of significant ventricular ectopy at the previous
ose. After each intervention, heart rate, blood pressure, and
V end-diastolic pressure were allowed to return to their
esting values before the next intervention. Plasma levels of
rain natriuretic peptide (BNP) were determined at rest
Triage MeterPlus, Merck, Whitehouse Station, New Jer-
ey). In addition, to screen for dynamic mitral regurgitation
3), an echo-Doppler examination was performed at rest
nd during the sustained hand-grip exercise.
chocardiography. Standard assessment of LV dimen-
ions, wall thickness, and mass was performed according to
ContinuedTable 1 Continued
HF
(n 
Echocardiography
LV end-diastolic diameter, mm 51
Left atrial diameter, mm 39
Left atrial volume index, ml/m2 34
Septum, mm 12
Posterior wall, mm 11
LV mass index g/m2 111
LV end-diastolic volume, ml 130
LV end-diastolic volume index, ml/m2 64
LV end-systolic volume, ml 71
LV end-systolic volume index, ml/m2 34
LV ejection fraction, % 62
LV diastolic function
Mitral flow E/A 0.8
Mitral E wave deceleration time, ms 238
Abnormal relaxation pattern 17
Pseudonormal pattern 3
Isovolumic relaxation time, ms 89
Septal E=, cm/s 5.6
Septal E/E= 12
Septal E/E= 15/9–14/8 4 (20)/8
Lateral E=, cm/s 6.8
Lateral E/E= 11
Lateral E/E= 12/9–11/8 8 (40)/4
Average E=, cm/s 6.3
Average E/E= 11
Average E/E= 13/9–12/8 6 (30)/6
Mild to moderate (2/4) MR 5
Right heart catheterization, mm Hg
PCWP 23
Systolic PAP 41
Values are mean  SD, n (%), or median (range). *Mann-Whitney U te
ACE angiotensin-converting enzyme; ARB angiotensin receptor bwith preserved ejection fraction; LV left ventricular; MImyocardial infarct
Heart Association; PAP  pulmonary artery pressure; PCI  percutaneous cohe joint recommendations of the European Association of
chocardiography, the American College of Cardiology,
nd the American Heart Association (4). LV volumes and
jection fraction were calculated using the biapical Simpson
ethod (4). Left atrial volume was derived by the biapical
rea-length method (4). Mitral flow was recorded as rec-
mmended (5). Pulse-wave tissue Doppler imaging was
erformed in the apical 4-chamber view to assess annular
arly and late diastolic velocities. In brief, the 5- to 10-mm
ampling volume was positioned within the septal and
ateral insertion sites of the mitral leaflets (5). The
ecording was performed at a sweep speed of 100 mm/s at
nd-expiratory apnea. The septal, lateral, and average
arly diastolic velocity (E=) were recorded, and the ratio
f mitral flow E wave to E= for each of these annular
elocities was calculated. The average of 3 consecutive
ardiac cycles was taken for measurement of each echo-
ardiographic index.
-V assessment: P-V catheterization was performed as
escribed previously (6). In brief, a 7-F combined pressure-
CON
(n  10)
p Value
HFPEF vs. CON
46 3 0.081
34 4 0.09
24 8 0.034
11 1 0.51
10 1 0.21
93 19 0.09
129 25 0.81
59 13 0.52
68 15 0.63
28 7 0.37
64 4 0.43
1.15 0.16 0.029
203 45 0.24
5 (50) 0.078
0 NA
75 19 0.18
8.0 2.5 0.032
9 3 0.046
(40) 0/4 (40)/6 (60) 0.28
10.9 1.9 0.021
7 2 0.023
(40) 2 (20)/2 (20)/6 (60) 0.5
9.5 1.8 0.038
8 2 0.042
(40) 1 (10)/3 (30)/6 (60) 0.42
2 (20) 1
7 4 0.001
25 12 0.033
BNP brain natriuretic peptide; CON control; HFPEF heart failurePEF
20)
 6
 8
 13
 2
 2
 35
 49
 16
 34
 12
 4
0.18
 71
(85)
(15)
 34
 1.5
 4
(40)/8
 2.1
 4
(20)/8
 1.6
 4
(30)/8
(25)
 12
 20
st.
locker;ion; MRmitral regurgitation; NA not available; NYHA New York
ronary intervention; PCWP  pulmonary capillary wedge pressure.
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HFPEF in Outpatients With Unexplained Dyspnea April 20, 2010:1701–10onductance catheter, with a 10-mm interelectrode spacing
CD Leycom, Zoetemeer, the Netherlands), was introduced
nto the left ventricle via the femoral artery. LV volume was
alibrated using thermodilution and hypertonic saline dilu-
ion (7,8). Hemodynamic indexes were calculated as the
ean of all beats, excluding extrasystoles, during a steady-
tate period of 20 s. Analysis of P-V loops was performed
sing commercial software (CD Leycom). LV function was
ssessed using heart rate; stroke volume, cardiac output; LV
nd-systolic and -diastolic pressures and volumes; LV ejec-
ion fraction; maximal and minimal rate of LV pressure
hange (dP/dtmax, dP/dtmin), and the relaxation time con-
tant (). LV end-systolic elastance was derived from the
nd-systolic pressure divided by the end-systolic volume.
nd-diastolic stiffness (EED) was estimated by dividing
nd-diastolic pressure by end-diastolic volume. Effective
rterial elastance (EA) was assessed as end-systolic pressure
ivided by stroke volume, and ventricular-arterial coupling
as calculated as LV end-systolic elastance/EA. LV mechan-
cal dyssynchrony was assessed as described previously (9).
efinition of HFPEF. HFPEF was defined at P-V cath-
terization by a LV end-diastolic pressure 16 mm Hg at
est or during hemodynamic interventions (5,10–12).
tatistical analysis. Data are presented as mean  SD.
roup comparisons were tested using the unpaired t test
nd chi-square test. Comparisons among hemodynamic
nterventions were performed using a repeated-measures
-way analysis of variance, with a Dunnett’s test for multiple
omparisons. The Fisher exact test was used to compare
ategorical variables in 2  2 contingency tables. Statistical
ignificance was defined as p  0.05.
esults
aseline characteristics. Patients were divided into HFPEF
nd control (CON) groups according to LV end-diastolic
ressure at catheterization. The HFPEF group (n  20)
onsisted of 17 patients with LV end-diastolic pressure16
m Hg at rest and 3 patients with normal resting values
hat increased significantly during hemodynamic interven-
ions. The remaining patients (n  10) with consistently
ower LV end-diastolic pressures served as the CON group.
aseline clinical characteristics of the 2 groups are shown in
able 1. Of the 30 study participants, most (73%) were
emale. Baseline clinical characteristics (which included
ersonal history, concomitant diseases, medications, and
ndings on physical examination) were similar in both
roups. Half of the patients had New York Heart Associ-
tion functional class III symptoms. The average duration of
ymptoms was slightly more than 1 year (range 0.5 to 4
ears). Hypertension was common in both groups. Seven
23%) patients had a history of coronary artery disease.
atients with HFPEF had significantly shorter exercise
uration than the CON group (p  0.001). Most of the
FPEF patients completed only 1 or 2 stages of exercise
ith a similar increase in heart rate as the controls. None ofhe patients showed signs of ischemia. BNP tended to be iigher in the HFPEF group compared with the CON
roup. However, only 3 patients from the HFPEF group
howed BNP values above the recommended European
ociety of Cardiology cutoff (200 pg/ml) for diagnosis of
FPEF. Five patients from the HFPEF and 1 patient from
he CON group showed BNP values that were borderline
100 to 200 pg/ml). The 12 remaining patients in the
FPEF group had normal BNP (100 pg/ml). The
ercentage of patients with abnormal chest X-rays, which
upported a diagnosis of heart failure, was similar in both
roups. None of the patients showed any signs of lung
ongestion. Patients with HFPEF had significantly larger
eft atrial volume and tended to show larger LV end-
iastolic diameter and LV mass compared with controls. LV
olume and ejection fraction were similar in both groups.
bnormal patterns of mitral inflow were observed in all
atients with HFPEF compared with only one-half of the
ontrols. Three patients from the HFPEF group and 1 from
he CON group met the European Society of Cardiology
utoff values (E/A 0.5 and DT 280 ms). Restrictive
itral flow was not observed in any of the patients. The
FPEF group showed significantly lower septal, lateral,
nd average E= and higher E/E= compared with the CON
roup. However, only 20%, 40%, and 30% from the
FPEF group had septal E/E= (15), lateral E/E= (12),
nd average E/E= (13), respectively, above the recom-
ended cutoff to diagnose increased LV filling pressures. In
ontrast, 20% to 40% of HFPEF patients showed nondiag-
ostic (borderline) E/E= and 40% normal E/E=. In the
ON group, up to 20% of patients showed diagnostic E/E=,
hereas 20% to 40% presented with borderline E/E= (p 
S compared with the HFPEF group). Prevalence of
ild-to-moderate mitral regurgitation did not differ be-
ween groups. Patients with HFPEF showed significantly
igher pulmonary capillary wedge pressures and systolic
ulmonary artery pressures than controls.
emodynamic interventions. Table 2 shows indices of
lobal LV performance. At rest, the HFPEF group had
ignificantly higher LV end-diastolic pressures and dyssyn-
hrony than the CON group. In contrast, cardiac output,
eart rate, LV volume, and ejection fraction were similar. In
oth groups, the end-diastolic pressure response to hemo-
ynamic interventions followed similar trends, which in-
reased during hand grip and leg lift and decreased during
itroprusside and dobutamine infusion. Three patients with
FPEF had normal resting values for end-diastolic pressure
ut showed a significant increase during both hand grip and
eg lift (n  2) or during dobutamine infusion (n  1).
oreover, the hand-grip exercise induced significant
3/4) mitral regurgitation in 2 patients who had only mild
egurgitation while at rest; both patients were in the
FPEF group. The leg lift was not associated with any
ignificant hemodynamic changes. Nitroprusside and do-
utamine infusions were associated with decreased volumes
nd increased ejection fraction and cardiac output (dobut-
mine). Average dyssynchrony did not change significantly
n response to hemodynamic changes.
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April 20, 2010:1701–10 HFPEF in Outpatients With Unexplained DyspneaTable 3 shows indices of LV systolic and diastolic
unction. At rest, patients with HFPEF had significantly
ndices of Global Left Ventricularerformance at R st and Duringmodynamic Int rventions (P-V Loop Analysis)
Table 2
Indices of Gl bal Left Ventricular
Performance at Rest and During
Hemodynamic Interventions (P-V Loop Analysis)
HFPEF
(n  20)
CON
(n  10)
p Value
HFPEF vs. CON
End-diastolic pressure, mm Hg
Rest 21 6.3 11 1.5 0.001
Hand grip 28 5.4* 13 1.6† 0.001
Leg lifting 24 4.3 14 1.0* 0.001
Nitroprusside infusion 13 5.3* 8 2.6* 0.028
Dobutamine infusion 16 8.4† 8 2.6* 0.019
p Value (ANOVA) 0.001 0.001
Cardiac output, l/min
Rest 4.9 1.5 5.3 1.00 0.47
Handgrip 4.9 1.3 5.5 1.2 0.4
Leg lifting 4.9 1.5 5.8 0.8 0.2
Nitroprusside 5.2 2.0 5.8 0.8 0.43
Dobutamine 6.2 2.3† 6.8 2.0† 0.61
p Value (ANOVA) 0.01 0.01
End-systolic volume, ml
Rest 67 27 66 11 0.88
Hand grip 75 28‡ 68 16 0.59
Leg lifting 72 28 63 12 0.52
Nitroprusside infusion 56 28* 50 17† 0.65
Dobutamine infusion 50 24* 51 16‡ 0.91
p Value (ANOVA) 0.001 0.001
End-diastolic volume, ml
Rest 138 45 139 20 0.94
Hand grip 139 45 136 19 0.82
Leg lifting 141 45 136 17 0.77
Nitroprusside infusion 119 47* 120 29* 0.99
Dobutamine infusion 115 53* 107 21* 0.64
p Value (ANOVA) 0.001 0.001
Ejection fraction, %
Rest 60 5 61 3 0.52
Hand grip 55 6 59 6 0.21
Leg lifting 59 6 64 4 0.045
Nitroprusside infusion 66 8‡ 67 5 0.76
Dobutamine infusion 68 11† 67 10 0.81
p Value (ANOVA) 0.001 0.019
Heart rate, beats/min
Rest 67 9 69 9 0.62
Hand grip 74 13 75 9 0.83
Leg lifting 68 9 71 8 0.58
Nitroprusside infusion 71 10 76 11‡ 0.25
Dobutamine infusion 93 12* 98 11* 0.35
p Value (ANOVA) 0.001 0.001
Dyssynchrony, %
Rest 28 7 19 7 0.009
Hand grip 29 5 20 10 0.005
Leg lifting 27 6 18 5 0.009
Nitroprusside infusion 27 6 20 5 0.004
Dobutamine infusion 27 7 21 7 0.002
p Value (ANOVA) 0.016 0.73
p 0.001 vs. baseline (Dunnett’s test for multiple comparison); †p 0.01 vs. baseline (Dunnett’s
est for multiple comparison); ‡p  0.05 vs. baseline (Dunnett’s test for multiple comparison).
ANOVA  analysis of variance; other abbreviations as in Table 1.igher end-systolic pressures and tended to have higher and-systolic elastance than controls. All indices of systolic
unction showed significant increases during dobutamine
nfusion in both groups compared with resting values. In
ontrast, handgrip, leg lift, and nitroprusside did not induce
ny significant changes. In the HFPEF group, the resting
V  was significantly longer and EED greater compared
ith the CON group. Dobutamine was associated with
ignificant shortening of  only in the CON group, although
n the HFPEF group, the average  value was also reduced,
ut insignificantly. EED increased in response to hand grip
n both groups but significantly more in patients with
FPEF. Nitroprusside reduced EED only in the HFPEF
roup. In addition, resting values of EA were higher in the
FPEF than in the CON group (2.23  0.72 vs. 1.66 
.23, respectively; p  0.025). In contrast, the ratio end-
ystolic elastance/EA, which defines ventricular-arterial cou-
ling, was similar in both groups (1.38  0.25 vs. 1.42 
.18, p 0.63) due to the compensatory higher end-systolic
lastance in the HFPEF group. The average values of major
emodynamic indices at baseline and during hemodynamic
nterventions are shown in Figure 1.
echanism of HFPEF. Figure 2 shows end-diastolic
-V relationships in both groups. In patients with
FPEF, the end-diastolic P-V relationship was consis-
ently shifted upward and leftward compared with con-
rols, regardless of the hemodynamic situation. A total of
4 (70%) patients with HFPEF had resting EED values
2 SDs (0.178 mm Hg/ml) higher than the highest
alue (0.144 mm Hg/ml) of EED in the CON group.
one of these patients had normal resting LV end-
iastolic pressures. Thus, in these individuals, the mark-
dly increased LV end-diastolic stiffness was considered to
e the underlying HFPEF mechanism (Table 4). Lower EED,
hich overlapped with that in the CON group, was ob-
erved in 6 (30%) patients with HFPEF. Severe mitral
egurgitation during the handgrip exercise developed in 2 of
hese patients, both with a history of myocardial infarction
nd hypokinesis in the segment adjacent to posterior
apillary muscle. They had resting LV end-diastolic
ressures within the normal range and showed normal
esting EED (0.085 and 0.091 mm Hg/ml). The 4
emaining HFPEF patients showed a concomitant pres-
nce of significant LV dyssynchrony and intermediate
ED (range 0.140 to 0.153 mm Hg). Three of these
atients had elevated resting LV end-diastolic pressures
nd very high degree of resting dyssynchrony (all 33% to
4%) (Fig. 3). The remaining patient had a normal
esting LV end-diastolic pressure and lower dyssyn-
hrony (23%); however, both parameters worsened dur-
ng dobutamine infusion. In addition, 1 patient in the
ON group had a very high resting dyssynchrony (30%)
hat did not worsen after administration of dobutamine.
he patient had a low EED (0.104 mm Hg/ml) and a
ormal LV end-diastolic pressure, both at rest and during
ll hemodynamic interventions.
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HFPEF in Outpatients With Unexplained Dyspnea April 20, 2010:1701–10iscussion
he major findings can be summarized as follows: 1) a
ignificant proportion of outpatients with unexplained
hronic dyspnea have HFPEF; 2) significant abnormalities
f LV diastolic function were observed in the majority of
ases and increased LV stiffness seemed to be the predom-
nant mechanisms underlying elevated LV filling pressures;
) in patients with moderately increased stiffness, severe LV
yssynchrony may contribute to HFPEF, whereas signifi-
Indices of Left Ventricular Systolic and Diastolicat Rest and During Hemodynamic InterventionsTable 3 Indices of Left Ventr ular Sys olicat Rest and During Hemodynamic In
HFPEF
(n  20)
End-systolic pressure, mm Hg
Rest 153 24
Hand grip 182 27*
Leg lifting 158 18
Nitroprusside 123 18‡
Dobutamine 135 32‡
p Value (ANOVA) 0.001
dP/dtmax , mm Hg/s
Rest 1,491 331
Hand grip 1,726 383
Leg lifting 1,536 356
Nitroprusside infusion 1,630 390
Dobutamine infusion 3,285 937*
p Value (ANOVA) 0.001
EES, mm Hg/ml
Rest 3.12 1.19
Hand grip 3.33 1.22
Leg lifting 3.36 1.33
Nitroprusside infusion 3.74 1.72
Dobutamine infusion 4.36 2.10
p Value (ANOVA) 0.001
dP/dtmin, mm Hg/s
Rest 1,964 691
Hand grip 2,093 693
Leg lifting 2,112 657
Nitroprusside infusion 1,737 539
Dobutamine infusion 2,167 930
p Value (ANOVA) 0.024
, ms
Rest 42 8
Hand grip 46 10
Leg lifting 43 8
Nitroprusside infusion 40 7
Dobutamine infusion 34 16
p Value (ANOVA) 0.009
EED, mm Hg/ml
Rest 0.205 0.07
Hand grip 0.259 0.07
Leg lifting 0.229 0.06
Nitroprusside infusion 0.139 0.04
Dobutamine infusion 0.186 0.06
p Value (ANOVA) 0.001
*p  0.001 vs. baseline (Dunnett’s test for multiple comparison); †p
baseline (Dunnett’s test for multiple comparison).
EED  end-diastolic stiffness; EES  end-systolic elastance;   relaant dyssynchrony alone is unlikely to be associated with ancreased filling pressures; and 4) in patients with a history of
yocardial infarction, some cases of HFPEF may be attribut-
ble to significant worsening of resting mild to moderate
unctional mitral regurgitation during increased afterload.
iagnosis of HFPEF. Diagnosis of heart failure is based
n symptoms and signs typical for heart failure, accompa-
ied by objective evidence of resting structural or functional
eart abnormalities including increased BNP levels and an
bnormal echocardiogram (13). The definition of HFPEF
ctionLo p Analysis)iastolic Function
ntions (P-V Loop Analysis)
CON
(n  10)
p Value
HFPEF vs. CON
127 12 0.006
144 14† 0.001
131 11 0.001
105 16‡ 0.007
104 25‡ 0.022
0.001
1,452 231 0.75
1,718 314 0.96
1,529 210 0.96
1,616 268 0.92
3,973 1079* 0.12
0.001
2.36 0.48 0.072
2.63 0.51 0.11
2.79 0.54 0.22
3.29 1.62 0.53
4.20 1.75* 0.85
0.001
2,129 383 0.5
2,393 343 0.22
2,186 363 0.75
2,067 383 0.12
2,244 408 0.81
0.13
34 3 0.005
36 4 0.004
33 3 0.002
34 3 0.012
25 4* 0.075
0.001
0.102 0.017 0.001
0.125 0.020† 0.001
0.130 0.015‡ 0.001
0.093 0.044 0.025
0.098 0.018 0.001
0.001
vs. baseline (Dunnett’s test for multiple comparison); ‡p  0.01 vs.
time constant; other abbreviations as in Tables 1 and 2.Fun(P-Vand D
terve
*
4
2*
9
5*
7
 0.05lso requires an LV ejection fraction 50%, LV end-
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April 20, 2010:1701–10 HFPEF in Outpatients With Unexplained Dyspneaiastolic volume index97 ml/m2, and evidence of diastolic
ysfunction (12). In the present study, HFPEF was diag-
osed by invasive measurement of LV end-diastolic pressure
sing a tip manometer catheter. This approach is considered
he gold standard for diagnosis of HFPEF, but may not be
easible in everyday clinical practice. In fact, in the absence
f the invasive pressure measurement, only 5 (25%) of our
FPEF outpatients but also 2 (20%) of our controls
ulfilled the European Society of Cardiology definition of
FPEF. Furthermore, in the HFPEF group, only 2 pa-
ients showed elevated BNP levels above the proposed
hreshold, and 6 patients had mitral flow patterns that
llowed increased LV filling pressures. In addition, using a
Figure 1 Hemodynamic Indices
Major hemodynamic indices at rest (RE), during hand grip (HG), leg lifting (LL), and
ejection fraction (red) and control (black) groups. *Statistically significant differen
CO  cardiac output; EDP  end-diastolic pressure; EDV  end-diastolic volume;
ESV  end-systolic volume.ulse-wave Doppler imaging–derived E/E= suggested HFPEF in hnly 20% to 40% of patients with increased LV filling
ressures, depending on the mitral annular site with highest
ield for the lateral E/E=. The remaining HFPEF showed
ither nondiagnostic (20% to 40%) or normal (40%) E/E=.
f interest, borderline E/E= was also noted in 20% to 40%
f controls without heart failure and with normal filings
ressure. This suggests a low sensitivity and specificity
elative to the proposed criteria for diagnosis of HFPEF in
table outpatients. A potential explanation may be that heart
ailure guidelines are based on large registries that include,
rimarily, patients hospitalized for heart failure (12,13). The
linical presentations, BNP levels, and echocardiographic
ndices may differ among patients with acute deteriorating
russide (NI) and dobutamine (DO) infusions in the heart failure with preserved
pared with baseline. #Statistically significant difference between both groups;
end-diastolic stiffness; Ees  end-systolic elastance; EF  ejection fraction;nitrop
ce com
Eed eart failure and stable outpatients with chronic dyspnea.
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HFPEF in Outpatients With Unexplained Dyspnea April 20, 2010:1701–10herefore, our findings support the more liberal use of right
eart catheterization to diagnose accurately HFPEF in such
utpatients. At catheterization, hemodynamic interventions
uch as simple hand grip or leg lift may be further helpful to
nmask HFPEF, as was elicited in 3 (15%) of our HFPEF
atients with normal LV end-diastolic pressures at rest.
echanisms of HFPEF. Recent studies have suggested
everal causal mechanisms underlying the onset of HFPEF
10,14–17). Corroborating findings of previous studies
10,14,15), we observed normal LV systolic functions,
ormal contractile reserves, and normal ventricular-arterial
oupling in patients with HFPEF, although it should be
oted that the load-independent derivation of the P-V
elationship was not used in the present study (14,18).
ence, the accuracy of systolic function assessment could be
educed by the fact that HFPEF patients had significantly
igher LV end-systolic pressure compared with controls.
lso, none of the patients showed reduced chronotropic
eserves (17) or significant renal insufficiency as a prerequi-
ite for fluid overload (16). The largest studies to date in
atients with HFPEF demonstrated an increased P-V–
erived LV stiffness as the main abnormality in HFPEF
14,15). Corroborating these findings, patients with HFPEF
howed consistent upward and leftward shifts of the LV
nd-diastolic P-V relationship compared with controls. A
otal of 14 (70%) patients with HFPEF showed markedly
ncreased LV stiffness, implicating it in the onset of HFPEF. In
hese patients, the increased stiffness was considered to be
he leading mechanism underlying increased LV filling
Figure 2 LV End-Diastolic Pressure Volume Relationship
Left ventricular (LV) end-diastolic pressure-volume relationship in the heart fail-
ure with preserved ejection fraction (red) and control (black) groups. Each
square indicates the average value of end-diastolic volume (EDV) (horizontal
error bars showing SEM) and end-diastolic pressure (EDP) (vertical error bars
showing SEM) at rest (RE), during hand grip (HG), leg lifting (LL), and nitroprus-
side (NI) and dobutamine (DO) infusions.ressures. Four (20%) patients had intermediate LV thick- Aess, which overlapped with the highest values measured in
he CON group. All these patients showed severe LV
yssynchrony at rest or during the dobutamine stress test.
his suggests that moderately increased LV thickness is not
ufficient to induce HFPEF and 1 or more additional
athologies are needed, for example, inotropic incompe-
ence (17), fluid overload (16), or (as in our case) significant
V dyssynchrony.
Several studies have demonstrated the high prevalence
18% to 45%) of significant dyssynchrony in patients with
FPEF (19–21). The presence of significant dyssynchrony
mpairs LV systolic and diastolic function (21). Corrobo-
ating these reports, in the present study, patients with
FPEF showed significantly higher resting dyssynchrony
ompared with controls. In individuals with moderately
ncreased LV stiffness with overlapping values between the
FPEF and control groups, the concomitant presence of
evere dyssynchrony seemed to be the critical mechanism
nderlying the development of HFPEF. It seems that, in
ontrast to systolic LV dysfunction (22–24), in patients with
ormal systolic function and LV stiffness, isolated dyssyn-
hrony, albeit significant, may not be a sufficient pathology
o induce or worsen heart failure. In the present study,
obutamine infusion induced a significant increase in end-
iastolic pressure due to worsening of LV dyssynchrony;
his was observed in 1 patient who had a normal resting LV
nd-diastolic pressure and lower resting dyssynchrony. Of
ote, this patient also had moderately elevated LV stiffness.
The remaining 2 (10%) HFPEF patients with normal LV
tiffness showed significant dynamic mitral regurgitation
uring the hand-grip exercise. Both patients had a history of
yocardial infarction, hypokinesis at the level of posterior
apillary muscle, and mild mitral regurgitation at rest. This
mplicates dynamic dyssynchrony and mitral regurgitation
n the development of symptoms in some patients with
FPEF. It also suggests that conducting stress tests may be
seful in patients after myocardial infarction with unex-
lained dyspnea.
tudy limitations. In the present study, the end-diastolic
-V relationship was not obtained using an acute preload
eduction during occlusion of inferior vena cava (14,18).
his method allows load-independent assessment of
entricular function. In the present study, the LV stiff-
ess was derived by a load-dependent method as the ratio
f end-diastolic pressure to end-diastolic volume. Yet the
esults were consistent with those of previous studies that
sed the multiple-loop, load-independent approach
14,25). The number of included patients is small, and,
otential Mechanism of Heart Failurei h Preserved Ejecti n Frac ionTable 4 Potential Mechan sm of Heart FailureWith Preserved Ejection Fraction
High EED
(>0.178 mm Hg/ml)
Low EED
(<178 mm Hg/ml)
HFPEF/CON, n (%) 14 (70)/0 (0) 6 (30)/10 (100)
Severe dynamic MR (3/4), n 0 2
Dyssynchrony, % 26 7 31 5/19 7bbreviations as in Tables 1 and 3.
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April 20, 2010:1701–10 HFPEF in Outpatients With Unexplained Dyspneaence, the results may not be applicable to the general
opulation of patients with HFPEF. In the present study,
he number of comparisons exceeds the number of
ubjects. This may result in the increase in type I error
false positive).
onclusions
sing invasive P-V loop analysis, the present study
emonstrated that increased LV stiffness, dynamic LV
yssynchrony, and dynamic mitral regurgitation were the
ajor mechanisms underlying the development of HF-
EF in stable patients with unexplained dyspnea in-
luded in this study. Because the majority of these
utpatients do not fulfill the diagnostic criteria for heart
ailure and noninvasive tests do not show overt pathol-
gy, a correct diagnosis of HFPEF represents a challenge.
fter negative findings on coronary angiography, the
atient’s symptoms are often attributed to noncardiac
auses. Yet, a cardiac origin of dyspnea is common in this
opulation and can be elucidated by careful invasive hemo-
ynamic assessment. Further studies should address the
evelopment of an optimal noninvasive workup suitable to
Figure 3 LV Dyssynchrony
Examples of 2 patients with heart failure with preserved ejection fraction. (A) A pa
patient with severe left ventricular dyssynchrony. In the first patient, the segmenta
diastole (D). In contrast, in the second patient, the onset of systole and diastole i
This results in inefficient left ventricular contraction against a closed aortic valve a
Note the severely increased end-diastolic stiffness (EED) in the patient in A and inteliably diagnose HFPEF in stable outpatients.cknowledgment
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